BlueRock Therapeutics LP
$405.9K 4 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Ivoclar Vivadent, Inc.
Ivoclar Vivadent, Inc. reported $405,694.10 across General Payments, Research, and Ownership to 1,041 physicians and teaching hospitals across 1,058 transactions.
- $405.7K Above-median payer
- All-tracks total
- 1,058 Above-median volume
- Transactions
- 1,041 Above-median reach
- Recipients
- −$119.7K
- General Payments vs PY2023
Ivoclar Vivadent, Inc. reported $405,694.10 across all CMS Open Payments tracks (General + Research + Ownership) to 1,041 physicians and teaching hospitals in Program Year 2024 - ranking #816 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $280,421.28, averaging $389.72 per recipient.
How Ivoclar Vivadent, Inc.'s $405.7K all-tracks total breaks down
Ivoclar Vivadent, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
38/100
Total payments
F
14/100
Transaction volume
F
18/100
Physician reach
F
18/100
Payment type diversity
A
100/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer ivoclar-vivadent-inc Ivoclar Vivadent, Inc.
$405.7K · #816/1,925 · 0.0% industry · PY2024
- TOT $405.7K
- RANK #816
- SHARE 0.0%
- TXN 1,058
- RCP 1,041
- CAT 8
- GEN $280.4K
- ΔGEN −$119.7K
- TOP1 9.4%
- PY 2024
Volume peers
Nearest volume peer: BlueRock Therapeutics LP ($405.9K)
Ivoclar Vivadent, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Ivoclar Vivadent, Inc.'s CMS-reported General Payments decreased by $119.7K (−29.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: IVOCLAR VIVADENT, INC.PY2023: IVOCLAR VIVADENT, INC.PY2024: Ivoclar Vivadent, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $400,119.48
- PY2024
- $280,421.28
What the Data Shows for Ivoclar Vivadent, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Ivoclar Vivadent, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
991 transactions worth $162.0K make "Food and Beverage" the top general-payment category in the 8-category breakdown below, 57.8% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads Ivoclar Vivadent, Inc.'s 8-category general-payment breakdown at $162.0K, 57.8% of the reported total.
Ivoclar Vivadent, Inc. reports 8 general-payment categories - the top three are Food and Beverage (57.8%), Honoraria (35.5%), and Education (2.9%). The remaining 5 categories make up 3.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Ivoclar Vivadent, Inc. files across 8 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Ivoclar Vivadent, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $162.0K | 991 | 57.8% |
| Honoraria | $99.5K | 16 | 35.5% |
| Education | $8.0K | 1 | 2.9% |
| Consulting Fee | $3.8K | 5 | 1.3% |
| Gift | $2.8K | 6 | 1.0% |
| Charitable Contribution | $1.9K | 5 | 0.7% |
| Entertainment | $1.3K | 9 | 0.4% |
| Travel and Lodging | $1.1K | 8 | 0.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $84,517.15 (30.1%) of $280,421.28 in this company's General Payments records across 725 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Ivoclar Vivadent, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Edward Mclaren
$26,384.83 across 6 reported transactions
- 2
David Rice
$17,122.31 across 14 reported transactions
- 3
Lee Brady
$14,151.25 across 3 reported transactions
- 4
Joyce Bassett
$13,467.39 across 8 reported transactions
- 5
Brian Lesage
$13,391.37 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Ivoclar Vivadent, Inc. ranks #816 of 1,925 by total payments (top 42% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,507 of 1,838 by HHI (bottom 18% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Avita Medical Americas, Llc : $545.0K total payments, HHI 257
- Core Surgical Group : $20.0K total payments, HHI 256
- Curonix LLC : $754.8K total payments, HHI 254
- Argon Medical Devices, Inc. : $147.3K total payments, HHI 254
- Averitas Pharma Inc. : $1.5M total payments, HHI 253
- Ambu A/S : $181.1K total payments, HHI 252
- Ivoclar Vivadent, Inc. (this company) : $280.4K total payments, HHI 251
- MDD US Operations, LLC : $1.7M total payments, HHI 249
- Olympus Medical Systems Corporation : $242.8K total payments, HHI 248
- Verrica Pharmaceuticals Inc. : $1.1M total payments, HHI 248
- Recordati_rare_diseases_inc. : $714.2K total payments, HHI 247
- Prism Medical : $34.0K total payments, HHI 247
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Ivoclar Vivadent, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Ivoclar Vivadent, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Ivoclar Vivadent, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Amarin Pharma Inc.
$405.1K 300 recipients
Compare payment profiles
Nova Eye, Inc.
$404.7K 474 recipients
Compare payment profiles
Mizuho America, Inc.
$403.0K 57 recipients
Compare payment profiles
Onkos Surgical, Inc.
$402.3K 461 recipients
Compare payment profiles
Geistlich Pharma, North America, Inc.
$401.7K 2,543 recipients
Compare payment profiles
Put this to use
Ivoclar Vivadent, Inc. ranks #816 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Ivoclar Vivadent, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.